Tissue expression
Cell line expression
Protein structure

VEGFA

Vascular endothelial growth factor A
VEGF, VEGF-A, VPF 
This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]
More gene data

All Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
2998 antibodies from 56 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Invitrogen Antibodies
120 antibodies
Novus Biologicals
159 antibodies
Proteintech Group
7 antibodies
antibodies-online
686 antibodies
R&D Systems
40 antibodies
GeneTex
29 antibodies
Biorbyt
243 antibodies
OriGene
119 antibodies
Abnova Corporation
27 antibodies
ReliaTech GmbH
13 antibodies
Acris Antibodies GmbH
81 antibodies
HUABIO Research
2 antibodies
NovoPro Bioscience Inc.
18 antibodies
Santa Cruz Biotechnology
1 antibody
Boster Biological Technology
8 antibodies
Affinity Biosciences
2 antibodies
Wuhan Fine Biotech Co., Ltd.
2 antibodies
SICGEN
1 antibody
NSJ Bioreagents
10 antibodies
St John's Laboratory
26 antibodies
Enzo Life Sciences
3 antibodies
Everest Biotech
2 antibodies
Cusabio Biotech Co., Ltd
9 antibodies
Abgent
8 antibodies
Abbiotec
4 antibodies
Aviva Systems Biology
11 antibodies
Bioworld Technology, Inc
5 antibodies
BioLegend
5 antibodies
Arigo
6 antibodies
Abbkine Scientific Co.Ltd.
3 antibodies
Sino Biological Inc.
8 antibodies
PeproTech Inc.
24 antibodies
Absolute Antibody
18 antibodies
Rockland Immunochemicals, Inc.
4 antibodies
RabMAbs
3 antibodies
Antibodies.com
1 antibody
Creative Diagnostics
25 antibodies
EMD Millipore
10 antibodies
United States Biological
137 antibodies
MyBioSource
40 antibodies
Leading Biology
16 antibodies
Abbexa
30 antibodies
GenWay
9 antibodies
RayBiotech, Inc.
6 antibodies
Creative Biolabs
450 antibodies
MilliporeSigma / Merck KGaA
6 antibodies
ProSci
5 antibodies
Atlas Antibodies
1 antibody
Spring Bioscience
5 antibodies
Abiocode, Inc.
1 antibody
BioLegend (formerly Covance Antibody Products)
1 antibody
DIMA
1 antibody
Aladdin Scientific Corporation
3 antibodies
MedChemExpress LLC
1 antibody